Havencrest Announces Team Promotions and Additions


Havencrest Capital Management, a Dallas-based, healthcare private equity firm, is pleased to announce several promotions and additions to its investment team.

Matthew D. Shofner has been promoted to Partner. Matt focuses on investments in healthcare services and technology-enabled healthcare services, with a particular focus on physician services companies and value-based care (VBC) reimbursement models. Matt serves on the Healthcare Advisory Council at the McCombs School of Business at the University of Texas at Austin.

M. Jett Aubrey has been promoted to Vice President. A former investment banker at Houlihan Lokey, Jett focuses on investments in healthcare services, with a particular focus on pharma services companies as well as post-acute care delivery models.

Thomas D. Ruane has recently joined the Havencrest team as Vice President of Business Development. Previously, Tom served as a Senior Associate of Business Development at Farragut Square Group (a subsidiary of McDermott Will & Emery), a leading healthcare policy and consulting firm with offices in Washington D.C. and New York City. Tom will be responsible for sourcing new investment opportunities for Havencrest as well as managing relationships with healthcare private equity, investment banker, lender and corporate customers.

“Havencrest is excited to announce these changes to our investment team,” said Christopher W. Kersey, Havencrest’s Founding Managing Partner. “Matt, Jett and Tom bring unique and complementary skill sets to our firm. As we continue to deploy our current fund, we look forward to partnering with leading founders and CEOs to build world-class healthcare companies.”

Havencrest's portfolio companies include these market leaders:

  • Effective School Solutions (ESS), a national leader in adolescent behavioral health
  • The Oncology Institute (TOI), the largest independent oncology practice in California and the nation’s largest physician-led provider delivering value-based care in oncology and
  • Apara Autism Centers, an outcomes-based, data-driven autism treatment services company.

Havencrest's investment team is complemented by its blue-chip network of Operating Partners and Senior Advisors, including many of the nation’s leading healthcare entrepreneurs, corporate executives and public policy experts.

Recent Deals

Interested in advertising your deals? Contact Edwin Warfield.